BRITTANY WESOLOWSKI: Open Payments
NPI 1396260824 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$303 in 9 payments from 7 companies in 2025. Trend: 2023 $1,376 · 2024 $258 · 2025 $303
Food & beverage: $303
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 1 | $144 |
| Genentech USA, Inc. | 2 | $46 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $42 |
| Janssen Biotech, Inc. | 1 | $19 |
| PFIZER INC. | 1 | $19 |
| Averitas Pharma Inc. | 1 | $18 |
| Biogen, Inc. | 1 | $15 |
Products named: PROCLAIM, Evrysdi, HYQVIA, PANZYGA, QUTENZA, SPINRAZA.
Industry payments across OH — which companies pay providers there.
